Peter M. Mauch

Q: What Schools Are Affiliated With Peter M. Mauch

Peter M. Mauch is affiliated with the following schools: University of Minnesota, Massachusetts General Hospital, University of Rochester, Harvard University

Peter M. Mauch's AcademicInfluence.com Rankings

Peter M. Mauch

Philosophy

#9505

World Rank

#13076

Historical Rank

Logic

#6480

World Rank

#8000

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Peter M. Mauch's Degrees

PhD Biomedical Sciences University of California, San Francisco
Doctorate Medicine University of California, San Francisco

Why Is Peter M. Mauch Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Peter M. Mauch's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Distribution of hematopoietic stem cells in the bone marrow according to regional hypoxia (2007) (854)
Cardiovascular status in long-term survivors of Hodgkin's disease treated with chest radiotherapy. (2004) (465)
Modern radiation therapy for Hodgkin lymphoma: field and dose guidelines from the international lymphoma radiation oncology group (ILROG). (2014) (450)
Hematopoietic stem cell compartment: acute and late effects of radiation therapy and chemotherapy. (1995) (435)
Second malignancy after Hodgkin disease treated with radiation therapy with or without chemotherapy: long-term risks and risk factors. (2002) (420)
Long-term survival and competing causes of death in patients with early-stage Hodgkin's disease treated at age 50 or younger. (2002) (405)
Long-term follow-up of autologous bone marrow transplantation in patients with relapsed follicular lymphoma. (1999) (371)
Prolonged disease-free survival after autologous bone marrow transplantation in patients with non-Hodgkin's lymphoma with a poor prognosis. (1987) (285)
Coronary artery disease mortality in patients treated for hodgkin's disease (2010) (277)
Myelodysplastic syndrome as a late complication following autologous bone marrow transplantation for non-Hodgkin's lymphoma. (1994) (270)
High-dose therapy and autologous bone marrow transplantation in patients with follicular lymphoma during first remission. (1996) (233)
Myeloablative therapy with autologous bone marrow transplantation for follicular lymphoma at the time of second or subsequent remission: long-term follow-up. (2007) (221)
Autologous and allogeneic stem cell transplantations for poor-risk chronic lymphocytic leukemia. (2005) (219)
Clinically significant cardiac disease in patients with Hodgkin lymphoma treated with mediastinal irradiation. (2011) (217)
The significance of mediastinal involvement in early stage Hodgkin's disease (1978) (200)
High-dose chemoradiotherapy and anti-B-cell monoclonal antibody-purged autologous bone marrow transplantation in mantle-cell lymphoma: no evidence for long-term remission. (1998) (196)
T-cell--depleted allogeneic bone marrow transplantation followed by donor lymphocyte infusion in patients with multiple myeloma: induction of graft-versus-myeloma effect. (2001) (193)
Second malignancies after treatment for laparotomy staged IA-IIIB Hodgkin's disease: long-term analysis of risk factors and outcome. (1996) (189)
Autologous bone marrow transplantation in B-cell non-Hodgkin's lymphoma: very low treatment-related mortality in 100 patients in sensitive relapse. (1990) (180)
Incidence of second cancers in patients treated for Hodgkin's disease. (1995) (177)
Autologous bone marrow transplantation in 69 patients with a history of low-grade B-cell non-Hodgkin's lymphoma. (1991) (175)
Outcome in patients with myelodysplastic syndrome after autologous bone marrow transplantation for non-Hodgkin's lymphoma. (1999) (175)
Stage IA and IIA supradiaphragmatic Hodgkin's disease: prognostic factors in surgically staged patients treated with mantle and paraaortic irradiation. (1988) (166)
Primary lymphomas of the central nervous system: patterns of failure and factors that influence survival. (1985) (159)
Evidence for structured variation in self-renewal capacity within long-term bone marrow cultures. (1980) (151)
The involved field is back: issues in delineating the radiation field in Hodgkin's disease. (2002) (151)
Mobilization of hematopoietic stem and progenitor cell subpopulations from the marrow to the blood of mice following cyclophosphamide and/or granulocyte colony-stimulating factor. (1993) (147)
Prevention of graft-versus-host disease by selective depletion of CD6-positive T lymphocytes from donor bone marrow. (1992) (144)
The significance of the residual mediastinal mass in treated Hodgkin's disease. (1985) (142)
Long-term survival in Hodgkin's disease relative impact of mortality, second tumors, infection, and cardiovascular disease. (1995) (139)
Thoracic irradiation in Hodgkin's disease: disease control and long-term complications. (1990) (138)
Long-term outcome and mortality trends in early-stage, Grade 1-2 follicular lymphoma treated with radiation therapy. (2006) (135)
Large-cell and immunoblastic lymphoma of the mediastinum: prognostic features and treatment outcome in 57 patients. (1993) (130)
Patterns of presentation of Hodgkin disease. Implications for etiology and pathogenesis (1993) (127)
FDG-PET is Superior to Gallium Scintigraphy in Staging and More Sensitive in the Follow-up of Patients with de novo Hodgkin Lymphoma: A Blinded Comparison (2004) (125)
Hodgkin Lymphoma Version 1.2017, NCCN Clinical Practice Guidelines in Oncology. (2017) (122)
Syngeneic and allogeneic bone marrow engraftment after total body irradiation: dependence on dose, dose rate, and fractionation. (1991) (118)
Late onset of renal dysfunction in survivors of bone marrow transplantation. (1987) (117)
Subsequent malignancies in children treated for Hodgkin's disease: associations with gender and radiation dose. (2008) (109)
Prognostic factors for positive surgical staging in patients with Hodgkin's disease. (1990) (108)
Early-stage, lymphocyte-predominant Hodgkin's lymphoma: patient outcomes from a large, single-institution series with long follow-up. (2010) (108)
An evaluation of long‐term survival and treatment complications in children with Hodgkin's disease (1983) (105)
Autologous bone marrow transplantation in poor-prognosis intermediate-grade and high-grade B-cell non-Hodgkin's lymphoma in first remission: a pilot study. (1993) (105)
Breast cancer screening in women previously treated for Hodgkin's disease: a prospective cohort study. (2002) (105)
Radiation Therapy for Solitary Plasmacytoma and Multiple Myeloma: Guidelines From the International Lymphoma Radiation Oncology Group. (2018) (102)
Decline in bone marrow proliferative capacity as a function of age. (1982) (102)
Hodgkin lymphoma, version 2.2012 featured updates to the NCCN guidelines. (2012) (100)
Hematopoietic stem cell deficit of transplanted bone marrow previously exposed to cytotoxic agents. (1993) (99)
Therapeutic guidelines and results in advanced seminoma. (1985) (97)
Prospective study of the efficacy of breast magnetic resonance imaging and mammographic screening in survivors of Hodgkin lymphoma. (2013) (92)
Clinical presentation and outcome in lymphocyte-predominant Hodgkin's disease. (1997) (91)
CD6-depleted allogeneic bone marrow transplantation for acute leukemia in first complete remission. (1997) (89)
Primary Ki-1 anaplastic large-cell lymphoma in adults: clinical characteristics and therapeutic outcome. (1993) (87)
Evidence-based review of three-dimensional conformal radiotherapy for localized prostate cancer: an ASTRO outcomes initiative. (2005) (83)
Prognostic significance of mid- and post-ABVD PET imaging in Hodgkin's lymphoma: the importance of involved-field radiotherapy. (2009) (82)
Improved survival following combined radiation therapy and chemotherapy for unfavorable prognosis stage I-II non-Hodgkin's lymphomas. (1985) (82)
Autologous bone marrow transplantation after histologic transformation of indolent B cell malignancies. (1999) (77)
Primary diffuse large B-cell lymphoma of the mediastinum: outcome following high-dose chemotherapy and autologous hematopoietic cell transplantation. (1998) (76)
Outcome after autologous and allogeneic stem cell transplantation for patients with multiple myeloma: impact of graft-versus-myeloma effect (2003) (73)
Stage I to IIB Hodgkin's disease: the combined experience at Stanford University and the Joint Center for Radiation Therapy. (1987) (72)
Fractionation and dose rate effects in mice: a model for bone marrow transplantation in man. (1987) (71)
Wide-field radiation therapy alone or with chemotherapy for Hodgkin's disease in relapse from combination chemotherapy. (1987) (71)
Influence of mediastinal adenopathy on site and frequency of relapse in patients with Hodgkin's disease. (1982) (70)
Quantitation of murine hematopoietic stem cells in vitro by limiting dilution analysis of cobblestone area formation on a clonal stromal cell line. (1993) (67)
Cost-effectiveness analysis of computerized tomography in the routine follow-up of patients after primary treatment for Hodgkin's disease. (2006) (67)
Permanent loss in stem cell self renewal capacity following stress to the marrow. (1988) (67)
Synergistic effects of interleukin-11 with other growth factors on the expansion of murine hematopoietic progenitors and maintenance of stem cells in liquid culture. (1994) (65)
High-dose cyclophosphamide, carmustine, and etoposide with autologous transplantation in Hodgkin's disease: a prognostic model for treatment outcomes. (1997) (64)
Palliation for carcinoma of the esophagus. (1976) (64)
Stage III Hodgkin's disease: improved survival with combined modality therapy as compared with radiation therapy alone. (1985) (61)
Immunogenicity of Ly5 (CD45)‐Antigens Hampers Long‐Term Engraftment Following Minimal Conditioning in a Murine Bone Marrow Transplantation Model (2001) (61)
THE EFFECT OF DONOR T LYMPHOCYTES AND TOTAL‐BODY IRRADIATION ON HEMOPOIETIC ENGRAFTMENT AND PULMONARY TOXICITY FOLLOWING EXPERIMENTAL ALLOGENEIC BONE MARROW TRANSPLANTATION (1992) (60)
T-cell-depleted autologous bone marrow transplantation therapy: analysis of immune deficiency and late complications. (1990) (60)
Treatment outcome of mucosa-associated lymphoid tissue/marginal zone non-Hodgkin's lymphoma. (2002) (59)
Granulocyte colony-stimulating factor enhances bone marrow stem cell damage caused by repeated administration of cytotoxic agents. (1998) (59)
Report from the Rockefellar Foundation Sponsored International Workshop on reducing mortality and improving quality of life in long‐term survivors of Hodgkin's disease: July 9–16, 2003, Bellagio, Italy (2005) (58)
Late Effects of Hodgkin’s Disease and Its Treatment (2009) (57)
Role of Radiation Therapy in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Guidelines from the International Lymphoma Radiation Oncology Group. (2018) (57)
Stage IA to IIB supradiaphragmatic Hodgkin's disease. Long‐Term survival and relapse frequency (1985) (57)
Long-term survival after autologous bone marrow transplantation for follicular lymphoma in first remission. (2007) (56)
HEPATIC DYSFUNCTION FOLLOWING T‐CELL-DEPLETED ALLOGENEIC BONE MARROW TRANSPLANTATION (1991) (56)
Anatomic substages of stage III-A Hodgkin's disease. A collaborative study. (1980) (56)
Renal insufficiency after total body irradiation for pediatric bone marrow transplantation. (1990) (56)
Controversies in the management of early stage Hodgkin's disease. (1994) (55)
Hodgkin's disease presenting below the diaphragm: a review. (1986) (55)
Patterns of relapse in large-cell lymphoma patients with bulk disease: implications for the use of adjuvant radiation therapy. (1989) (53)
Radiation therapy for orbital lymphoma. (2004) (53)
Unilateral and bilateral breast cancer in women surviving pediatric Hodgkin's disease. (2008) (52)
Long-term follow-up of a phase III study of recombinant human granulocyte-macrophage colony-stimulating factor after autologous bone marrow transplantation for lymphoid malignancies. (1993) (52)
CD6+ donor marrow T-cell depletion as the sole form of graft-versus-host disease prophylaxis in patients undergoing allogeneic bone marrow transplant from unrelated donors. (2001) (51)
Epstein-Barr virus in Hodgkin's disease: correlation of risk factors and disease characteristics with molecular evidence of viral infection. (1998) (51)
Granulocyte‐Colony Stimulating Factor Impedes Recovery from Damage Caused by Cytotoxic Agents through Increased Differentiation at the Expense of Self‐Renewal (2000) (50)
Loss of hematopoietic stem cell self-renewal after bone marrow transplantation (1989) (49)
ENGRAFTMENT FOLLOWING T‐CELL‐DEPLETED MARROW TRANSPLANTATION: I. THE ROLE OF MAJOR AND MINOR HISTOCOMPATIBILITY BARRIERS (1987) (49)
Total lymphoid irradiation to prevent graft rejection in recipients of HLA non-identical T cell-depleted allogeneic marrow. (1991) (47)
Predictive factors for radiation pneumonitis in Hodgkin lymphoma patients receiving combined-modality therapy. (2012) (46)
In vivo somatic mutation in the lymphocytes of Hodgkin's disease patients (1991) (45)
Hodgkin lymphoma, version 2.2015. (2015) (44)
The significance of mediastinal involvement in early stage Hodgkin's disease. (1977) (44)
Primary mediastinal large-B-cell lymphoma: radiologic findings at presentation. (1996) (43)
Hematopoietic stem cells in the blood after stem cell factor and interleukin-11 administration: evidence for different mechanisms of mobilization. (1995) (43)
Low-dose involved-field radiation in the treatment of non-hodgkin lymphoma: predictors of response and treatment failure. (2012) (43)
Stage IA-IIB Hodgkin's disease: staging and treatment of patients with large mediastinal adenopathy. (1989) (43)
RECIPIENT PREPARATION FOR BONE MARROW TRANSPLANTATION I. EFFICACY OF TOTAL‐BODY IRRADIATION AND BUSLFAN (1988) (41)
Anatomic substages of stage IIIA Hodgkin's disease: followup of a collaborative study. (1982) (41)
Prognostic factors for patients with Hodgkin disease in first relapse (1993) (41)
Response to low-dose involved-field radiotherapy in patients with non-Hodgkin's lymphoma. (2008) (40)
Role of radiation therapy in the treatment of Hodgkin's disease. (1982) (38)
CD6+ T cell-depleted allogeneic bone marrow transplantation for non-Hodgkin’s lymphoma (1998) (38)
Wide‐field radiation therapy with or without chemotherapy for patients with Hodgkin disease in relapse after initial combination chemotherapy (1993) (38)
The Role of Radiation Therapy in Patients With Relapsed or Refractory Hodgkin Lymphoma: Guidelines From the International Lymphoma Radiation Oncology Group. (2018) (37)
What is the appropriate systemic chemotherapy for lymphocyte-predominant Hodgkin's lymphoma? (2010) (37)
Loss of hematopoietic stem cell self-renewal after bone marrow transplantation. (1989) (36)
Partial CD8+ T-cell depletion of allogeneic peripheral blood stem cell transplantation is insufficient to prevent graft-versus-host disease (2004) (36)
Hodgkin's disease in elderly patients (> or =60): clinical outcome and treatment strategies. (2003) (36)
Circulating lymphocyte populations in Hodgkin's disease after mantle and paraaortic irradiation. (1983) (35)
Sexual functioning in long‐term survivors of Hodgkin's lymphoma (2010) (35)
Role of radiation therapy in the treatment of stage I/II mucosa-associated lymphoid tissue lymphoma. (2006) (35)
Supradiaphragmatic Hodgkin's disease: is there a role for MOPP chemotherapy in patients with bulky mediastinal disease? (1980) (35)
Cyclophosphamide, Doxorubicin, Vincristine, Prednisone Dose Intensification With Granulocyte Colony-Stimulating Factor Markedly Depletes Stem Cell Reserve for Autologous Bone Marrow Transplantation (1997) (34)
Computed tomography screening for lung cancer in Hodgkin's lymphoma survivors: decision analysis and cost-effectiveness analysis. (2006) (34)
Planning mantle radiation therapy in patients with Hodgkin disease: role of gallium-67 scintigraphy. (1988) (33)
CD6+ T cell depleted allogeneic bone marrow transplantation from genotypically HLA nonidentical related donors. (1997) (33)
Hodgkin disease/lymphoma. Clinical practice guidelines in oncology. (2006) (33)
Low-dose chest computed tomography for lung cancer screening among Hodgkin lymphoma survivors: a cost-effectiveness analysis. (2014) (33)
Stem cell self-renewal considerations in bone marrow transplantation. (1989) (32)
A prospective study of pulmonary function in Hodgkin's lymphoma patients. (2007) (32)
Radiation-associated breast cancer after Hodgkin's disease: risks and screening in perspective. (1992) (32)
Sca+CD34- murine side population cells are highly enriched for primitive stem cells. (2003) (32)
Host conditioning with 5-fluorouracil and kit-ligand to provide for long-term bone marrow engraftment. (1997) (31)
Effect of total body irradiation dose escalation on outcome following T-cell-depleted allogeneic bone marrow transplantation. (2002) (31)
Radiation Oncology: Technology and Biology (1994) (30)
The development of Graves' disease following radiation therapy in Hodgkin's disease. (1988) (30)
Loss of marrow reserve from dose-intensified chemotherapy results in impaired hematopoietic reconstitution after autologous transplantation: CD34(+), CD34(+)38(-), and week-6 CAFC assays predict poor engraftment. (2000) (29)
Posttraumatic stress disorder (PTSD) in survivors of Hodgkin's lymphoma: prevalence of PTSD and partial PTSD compared with sibling controls (2011) (29)
Clinical and Pathologic Features of Breast Cancers in Women Treated for Hodgkin's Disease: A Case‐Control Study (2001) (29)
Cannabinoid receptor 2 and its agonists mediate hematopoiesis and hematopoietic stem and progenitor cell mobilization. (2011) (28)
Reduction of fatal complications from combined modality therapy in Hodgkin's disease. (1985) (28)
Role of radiation therapy in localized aggressive lymphoma. (2007) (27)
Primary systemic treatment of advanced Hodgkin's disease with EVA (etoposide, vinblastine, doxorubicin): 10-year follow-up. (2003) (26)
Nodular lymphocyte-predominant hodgkin lymphoma. (2007) (26)
Long-term complications of MOPP chemotherapy in patients with Hodgkin's disease. (1982) (26)
Early-stage mantle cell lymphoma: a retrospective analysis from the International Lymphoma Radiation Oncology Group (ILROG) (2017) (26)
Stage IA-IIB Hodgkin's disease: management and outcome of extensive thoracic involvement. (1997) (26)
Salvage radiotherapy in patients with recurrent or refractory primary or secondary central nervous system lymphoma after methotrexate-based chemotherapy. (2011) (25)
Mantle irradiation alone for selected patients with laparotomy-staged IA to IIA Hodgkin's disease: preliminary results of a prospective trial. (1995) (25)
Lung metastases in cervical and endometrial carcinoma. (1979) (25)
Decision analysis on alternative treatment strategies for favorable-prognosis, early-stage Hodgkin's disease. (1999) (24)
Cost effectiveness and screening interval of lipid screening in Hodgkin's lymphoma survivors. (2009) (24)
Laparotomy versus no laparotomy in the management of early-stage, favorable-prognosis Hodgkin's disease: a decision analysis. (1999) (23)
Comparable outcome with T-cell-depleted unrelated-donor versus related-donor allogeneic bone marrow transplantation. (2002) (23)
Influence of new late effects on quality of life over time in Hodgkin lymphoma Survivors: a longitudinal survey study. (2013) (22)
Radiation therapy in stage II ovarian carcinoma. The influence of histologic grade (1980) (22)
Combined modality treatment for PET-positive non-Hodgkin lymphoma: favorable outcomes of combined modality treatment for patients with non-Hodgkin lymphoma and positive interim or postchemotherapy FDG-PET. (2012) (21)
Dose-limiting complications from upper half body irradiation in C3H mice. (1988) (21)
Functional organization of the hematopoietic stem cell compartment: implications for cancer and its therapy. (1983) (21)
Lung malignancies after Hodgkin lymphoma: disease characteristics, detection methods and clinical outcome. (2012) (20)
Late complications of therapy of Hodgkin's disease: prevention and management. (2004) (20)
Radiographic features of recurrent intrathoracic Hodgkin's disease following radiation therapy. (1979) (20)
Controversies in the use of diagnostic staging laparotomy and splenectomy in the management of Hodgkin's disease. (1992) (19)
The influence of initial pathologic stage on the survival of patients who relapse from Hodgkin's disease. (1980) (19)
Peri- and paracardial involvement in lymphoma: a radiographic study of 11 cases. (1983) (19)
Lymphoid irradiation results in long‐term increases in natural killer cells in patients treated for Hodgkin's disease (1992) (19)
Cell types associated with fibronectin in long-term mouse bone marrow cultures. (1982) (18)
Results of a prospective trial of mantle irradiation alone for selected patients with early-stage Hodgkin's disease. (2001) (18)
Clinical course of thoracic cancers in Hodgkin's disease survivors. (2005) (18)
A prospective study of salivary gland function in lymphoma patients receiving head and neck irradiation. (2009) (18)
Autologous Bone Marrow Transplantation for Marginal Zone Non-Hodgkin's Lymphoma (2004) (17)
ENGRAFTMENT FOLLOWING T CELL‐DEPLETED BONE MARROW TRANSPLANTATION: III. DIFFERENTIAL EFFECTS OF INCREASED TOTAL‐BODY IRRADIATION ON SEMIALLOGENEIC AND ALLOGENEIC RECIPIENTS (1988) (17)
Reduced Mortality Risk in the Recent Era in Early-Stage Hodgkin Lymphoma Patients Treated With Radiation Therapy With or Without Chemotherapy. (2018) (16)
Hodgkin disease/lymphoma. (2008) (16)
ENGRAFTMENT FOLLOWING T‐CELL-DEPLETED BONE MARROW TRANSPLANTATION II. STABILITY OF MIXED CHIMERISM IN SEMIALLOGENEIC RECIPIENTS AFTER TOTAL‐BODY IRRADIATION (1987) (15)
Management of early stage Hodgkin's disease: the role of radiation therapy and/or chemotherapy. (1996) (15)
Hodgkin lymphoma. (2021) (14)
Mediastinal Large Cell Lymphoma: Prognostic Significance ofCT Findings at Presentation and after Treatment (1998) (14)
Health practice in long-term survivors of Hodgkin's lymphoma. (2008) (14)
Radioprotection of bone marrow stem cell subsets by interleukin-1 and kit-ligand: implications for CFU-S as the responsible target cell population. (1997) (14)
Protrusio acetabuli following pelvic irradiation. (1979) (14)
Cyclophosphamide, doxorubicin, vincristine, prednisone dose intensification with granulocyte colony-stimulating factor markedly depletes stem cell reserve for autologous bone marrow transplantation. (1997) (13)
Late tissue-specific toxicity of total body irradiation and busulfan in a murine bone marrow transplant model. (1989) (13)
Combined treatment methods for carcinoma of the esophagus. (1978) (13)
Controversies in early-stage Hodgkin's disease. (2002) (13)
Radiotherapy in the management of localized primary cutaneous B-cell lymphoma (2013) (12)
Practice guideline for the performance of therapy with unsealed radiopharmaceutical sources. (2006) (12)
The role of radiotherapy for early stage Hodgkin's disease: limitations and perspectives. (1998) (11)
Mid- and post-ABVD gallium scanning predicts for recurrence in early-stage Hodgkin's disease. (2005) (11)
Costs and effectiveness of staging and treatment options in early-stage Hodgkin's disease. (2001) (11)
Follicular non-Hodgkin's lymphoma: the role of radiation therapy (2001) (11)
Mutagenesis after cancer therapy. (1993) (11)
Treatment of patients with "minimal" stage IIIA Hodgkin's disease. (1987) (11)
The importance of staging laparotomy in pediatric Hodgkin's disease. (1994) (11)
Radiation therapy in stage II ovarian carcinoma: the influence of histologic grade. (1980) (10)
Long-term results of a prospective trial of mantle irradiation alone for early-stage Hodgkin's disease. (2006) (10)
Improved survival in patients with limited stage IIIA Hodgkin's disease treated with combined radiation therapy and chemotherapy. (1994) (9)
Mantle irradiation in the upright position: a technique to reduce the volume of lung irradiated in patients with bulky mediastinal Hodgkin's disease. (1992) (9)
Factors influencing treatment recommendations in early-stage Hodgkin's disease: a survey of physicians. (2004) (9)
Radiation therapy in Hodgkin's lymphoma. (1999) (9)
Significance of epitrochlear lymph node involvement in Hodgkin disease (2001) (9)
Recombinant Adeno‐Associated Virus‐Based Vectors Provide Short‐Term Rather Than Long‐Term Transduction of Primitive Hematopoietic Stem Cells (1999) (8)
The Second International Symposium on Hodgkin's Disease. Workshop I: Review on prognostic factors. (1992) (8)
Respiratory burst of neutrophils is not required for stem cell mobilization in mice (2000) (8)
Stem-cell biology and cancer therapy: the more things change... (2008) (8)
Advances in the treatment of Hodgkin lymphoma. (2006) (8)
Primary bone lymphoma involving bilateral tibia (2012) (8)
What is the role for adjuvant radiation therapy in advanced Hodgkin's disease? (1998) (7)
Monoclonal antibody-purged bone marrow transplantation therapy for multiple myeloma. (1995) (7)
The impact of treatment on the risk of second malignancy after Hodgkin's disease. (2006) (7)
Clinical outcome of patients with early stage favorable Hodgkin lymphoma treated with ABVD × two cycles followed by FDG-PET/CT restaging and 20 Gy of involved-site radiotherapy (2018) (7)
Reduction of lethal graft-versus-host disease: transplantation of cultured murine bone marrow across minor histocompatibility differences (1985) (7)
Bone marrow transplantation: The genetic and cellular basis of resistance to engraftment and acute graft-versus-host disease (1985) (6)
Phenotypic and functional analysis of expanded natural killer cell subpopulations in Hodgkin's disease patients treated with lymphoid irradiation. (1993) (6)
International Database on Hodgkin's Disease: a cooperative effort to determine treatment outcome. (1992) (6)
Workshop I: Review on prognostic factors (1992) (6)
Management of early stage Hodgkin's disease: the role of radiation therapy and/or chemotherapy. (1996) (6)
Reduction of treatment for early stage Hodgkin's disease. (1992) (5)
Implications of a proliferative limitation on hematopoietic stem cells. (1984) (5)
The role of postoperative local or regional irradiation in the treatment of stage I ovarian cancer. (1982) (5)
A prospective study of hprt mutant and mutation frequencies in treated cancer patients. (1992) (5)
Fatigue in long-term survivors of Hodgkin’s disease is associated with underlying cardiac disease (2004) (5)
Defining the Bone Marrow Stem Cell Niche According to a Hoechst Dye Diffusion Gradient and Hypoxia. (2004) (5)
Removal of carcinoma cells from contaminated bone marrow using the lipophilic cation rhodamine 123. (1995) (4)
Comparison of MOPP versus ABVD as salvage therapy in patients who relapse after radiation therapy alone for Hodgkin's disease. (2004) (4)
Three-dimensional dose distribution of total body irradiation by a dual source total body irradiator. (1992) (4)
Lethal graft-versus-host disease: modification with allogeneic cultured donor cells. (1984) (4)
CD 6-Depleted Allogeneic Bone Marrow Transplantation for Acute Leukemia in First Complete Remission (1997) (4)
Management and outcomes of women diagnosed with primary breast lymphoma: a multi-institution experience (2018) (4)
Low-Dose Chest CT for Lung Cancer Screening Among Hodgkin Lymphoma Survivors: A Cost-Effectiveness Analysis (2013) (4)
Current role of radiotherapy in Hodgkin's and non‐Hodgkin's lymphoma (1995) (4)
TREATMENT OF ADVANCED HODGKIN’S DISEASE (1977) (4)
Favorable Outcome in Stage I-II Mantle Cell Lymphoma: A Report of 160 Patients From the International Lymphoma Radiation Oncology Group (ILROG) (2014) (3)
Initial relapses in previously treated Hodkin's disease (1979) (3)
Transplantation with anti-B1 monoclonal antibody and complement treated autologous bone marrow for relapsed B-cell non-Hodgkin’s lymphoma (1985) (3)
Four-dimensional versus 3-dimensional computed tomographic planning for gastric mucosa associated lymphoid tissue lymphoma. (2013) (3)
Mutagenesis after therapy for Hodgkin's disease. (1993) (3)
Murine side population cells contain cobblestone area-forming cell activity in mobilized blood. (2005) (3)
Mantle irradiation alone for selected patients with pathologically staged (PS) Ia–IIa Hodgkin's disease: Preliminary results of a prospective trial (1993) (3)
Case 43-1984: A 35-Year-Old Woman with Tracheal Stenosis after Treatment for Hodgkin's Disease (1984) (3)
Long-term survival and competing causes of death in Hodgkin's disease (HD) (2000) (3)
Low-dose total body irradiation and G-CSF without hematopoietic stem cell support in the treatment of relapsed or refractory acute myelogenous leukemia (AML), or AML in second or subsequent remission. (1998) (3)
The role of MOPP chemotherapy in early stage Hodgkin's disease (1984) (2)
Technologic advancements and error rates in radiation therapy (RT) delivery. (2010) (2)
Hodgkin's disease: a clinical perspective (1985) (2)
Second malignancy after Hodgkin’s disease: Long-term risk and risk factors (2001) (2)
Hodgkin's disease—Part I: Epidemiology, pathology, staging and management of early stage disease (1996) (2)
Cardiac status predicts quality of life in Hodgkin's disease survivors. (2006) (2)
Follow-up of Hodgkin's disease. American College of Radiology. ACR Appropriateness Criteria. (2000) (2)
Hodgkin Lymphoma Version 1 . 2017 Clinical Practice Guidelines in Oncology (2017) (2)
A Prospective Cardiac Screening Study in Asymptomatic Long-term Survivors of Hodgkin's Lymphoma Treated with Mediastinal Radiation Therapy (2010) (2)
Treatment outcome and pulmonary toxicity of ABVD chemotherapy for Hodgkin’s disease (2002) (1)
168 : Cost-effectiveness of Lipid Screening in Hodgkin’s Disease Survivors (2006) (1)
A randomized phase II trial of amifostine for head and neck irradiation in lymphoma. (2004) (1)
A novel method of purging carcinoma contaminated bone marrow, using the lipophilic cation, rhodamine 123 (1992) (1)
Hodgkin's disease: controversies in staging and treatment (1989) (1)
cyclophosphamide and/or granulocyte colony-stimulating factor subpopulations from the marrow to the blood of mice following Mobilization of hematopoietic stem and progenitor cell (2011) (1)
Response to "Dilemmas and decisions". (1990) (1)
Cost-effectiveness of computerized tomography screening for lung cancer in Hodgkin’s disease survivors (2003) (1)
Local Progression after Low-dose Involved-field Radiation for Non-Hodgkin Lymphoma (2009) (1)
Peripheral Blood Stem Cell Transplantation: Predictions from Studies in the Mouse (1993) (1)
Breast cancer after treatment for pediatric Hodgkin’s disease is most common in girls with early stage (2001) (1)
Pediatric Hodgkin's disease. American College of Radiology. ACR Appropriateness Criteria. (2000) (1)
Staging evaluation for patients with Hodgkin's disease. American College of Radiology. ACR Appropriateness Criteria. (2000) (1)
Reduction of lethal graft-versus-host disease: transplantation of cultured murine bone marrow across minor histocompatibility differences. (1985) (1)
Radiation sensitivity and heterogeneity of hemopoietic stem cells. (1994) (1)
Stage III and IV Hodgkin's disease treatment guidelines. American College of Radiology. ACR Appropriateness Criteria. (2000) (1)
Predictors of Symptomatic Failure after Palliative Radiation Therapy for Multiple Myeloma (2009) (1)
The lymphomas: current concepts in pathogenesis and management. Washington, D.C., September 21-23, 1989. Proceedings. (1990) (1)
Long-Term Competing Mortality in Early-Stage Hodgkin Lymphoma: Reduced Mortality Risk in Patients Treated in the Modern Era (2014) (1)
Whole lung irradiation in Hodgkin's disease: Local control and complications (1989) (1)
Four-Dimensional CT Planning for Gastric MALT Lymphoma (2011) (1)
Mdr1 gene-expression in a multidrug-resistant human non-hodgkins-lymphoma xenograft model. (1993) (0)
Abstract 19696: Hypertension and Elevated hs-CRP Predict Occult Cardiovascular Disease in Asymptomatic Survivors of Hodgkin's Lymphoma Treated with Chest Radiation (2012) (0)
Lymphoma, Hodgkin's Disease (2002) (0)
Cost-effectiveness of Routine Computerized Tomography in Follow-up of Patients with Complete Response After Primary Treatment for Hodgkin’s Disease (2005) (0)
Management of Lymphocyte Predominant Hodgkin Lymphoma (2011) (0)
Primary Treatment Classical Hodgkin Lymphoma : Lymphocyte-predominant Hodgkin Lymphoma : NCCN Hodgkin Disease / Lymphoma Panel Members Summary of Guidelines Updates (2001) (0)
Heterogeneity of self renewal potential in hematopoietic stem cells cultured in vitro. Abstr. (1979) (0)
Radiotherapy for Management of Localized Primary Cutaneous B-cell Lymphoma (2011) (0)
403C Hodgkin's disease — Part II: Management of advanced-stage disease, relapsed disease and long-term complications of treatment (1995) (0)
Abstract of ASTR scientific papers to be presentedStage I carcinoma of the ovary: The influence of histologic grade (1979) (0)
Does adjuvant radiation therapy hold promise for improved outcome in advanced Hodgkin's disease? (1995) (0)
Use of donor allogeneic cultured cells in bone marrow transplantation. Abstr. (1982) (0)
Proceeding of the 37th Annual ASTRO meeting ASTRO refresher course abstract403 Hodgkin's disease — part 2: Management of advanced disease, relapsed disease, and long-term complications of treatment (1995) (0)
Prognostic factors for hodgkin's disease patients in first relapse (1991) (0)
Treatment of Stage I-II Hodgkin's Disease (2003) (0)
2524 : Role of Radiation Therapy in the Treatment of Stage I/II MALT Lymphoma (2006) (0)
Hematopoietic Stem Cell Defects in Novel Fanconi Anemia Mouse Models (2008) (0)
Modern radiation therapy for hodgkin lymphom-target definition and dose guidelines from the international lymphoma radiation oncology group (2017) (0)
Histologic subclassification does not predict for outcome in pathologically staged IA-11113 nodular sclerosis Hodgkin's disease (1993) (0)
Long-Term Results of a Prospective Trial of Mantle Irradiation (RT) Alone for Early-Stage Hodgkin’s Disease (HD) (2005) (0)
22 A prospective trial of mantle irradiation alone for selected patients with PS IA - IIA Hodgkin's disease (1996) (0)
Title of Paper: Treatment of PSIII1A Hodgkin's disease kith subtotal nodal irradiation (1992) (0)
1011 Comparison of MOPP versus ABVD as salvage therapy in patients who relapsed after radiation therapy alone for Hodgkin's disease (2003) (0)
Clinical features and treatment of MALT lymphoma (1999) (0)
169 : Health Practice in Long-Term Survivors of Hodgkin’s Disease (2006) (0)
Laparotomy V ersus N o L aparotomy i n t he M anagement of E arly-Stage, F avorable-Progno sis H odgkin's D isease: A D ecision A nalysis (1999) (0)
Management and Outcomes of Women Diagnosed With Primary Breast Lymphoma (2017) (0)
136 Hodgkin's disease in the elderly patients (60 or older): Clinical outcome and treatment strategies (1999) (0)
Salvage Radiotherapy in Patients with Recurrent or Refractory CNS Lymphoma (2010) (0)
Methode de depletion selective de cellules hypoxiques (2006) (0)
Current status of radiotherapy and combined treatment modalities. (1989) (0)
The role of staging laparotomy in combined modality therapy of Hodgkin's disease: A new treatment plan based on a 6-year experience (2005) (0)
Long-Term Risk of Cardiac Events Requiring Interventions in Survivors of Hodgkin's Lymphoma (HL) Treated With Mediastinal Irradiation (2007) (0)
89: Defining the Hypoxic Stem Cell Niche in Bone Marrow: Possible Role of Reoxygenation in Homeostatic Control of Hematopoiesis After Chemotherapy (2006) (0)
149 External-beam boost prior to totalbody irradiation in rflapsed NHL transplant patients (1995) (0)
172 Second malignant neoplasms in children treated for hodgkin's disease (1999) (0)
Epidemiology and Etiology (2003) (0)
Predictive Factors for Ophthalmic Toxicity in Patients Receiving Radiation Therapy for Ocular Adnexal or Periorbital Lymphoma (2014) (0)
Alterations in natural killer subsets in patients treated for Hodgkin's disease (1986) (0)
CULTURED CELLS IN MARROW TRANSPLANTATION 1113 recipients of cultured marrow cells with major H-2 histocompatibility differences (2005) (0)
Oral Scientific SessionsThe Impact of Radiation Field Size on Long-Term All-Cause Mortality of Stage I-II Hodgkin Lymphoma Patients (2017) (0)
1025 Long-term outcome and mortality trends in follicular lymphoma treated with radiation therapy (2003) (0)
Prognostic factors in asymptomatic hodgkin's disease, stages IA–IIIA (1980) (0)
Management and long-term outcome of patients presenting with clinical stage IA–IIB Hodgkins disease with extensive thoracic involvement (1994) (0)
Low mortality from lymphocyte predominant hodgkin's disease with long-term follow-up (1994) (0)
Prognostic factors in stage I and II diffuse large cell lymphoma patients treated with multiagent chemotherapy alone or combined with radiation therapy (1992) (0)
Response to Low-Dose Involved-Field Radiotherapy (LD-IF-RT) in Patients With Non-Hodgkin's Lymphoma (NHL) (2007) (0)
204: Secondary Bone and Soft Tissue Sarcomas In Children Treated for Hodgkin Lymphoma (2006) (0)
Treatment of hodgkin's disease patients with bulky mediastinal nodes in the upright mantle position (1989) (0)
Hodgkin's disease:Current controversies in staging and treatment (1987) (0)
in First Complete Remission CD6-Depleted Allogeneic Bone Marrow Transplantation for Acute Leukemia (2013) (0)
Long-Term Follow-Up of Autologous Bone Marrow Transplantation for Follicular Lymphoma in First Remission: Bone Marrow Involvement at Harvest and PCR Detectable Disease after Ex Vivo Purging Predict Relapse. (2006) (0)
Autologous Bone Marrow Transplantation for Follicular Lymphoma in First Remission: Long Term Follow up of Two Sequential Trials with Standard Dose and High Dose CHOP Induction. (2004) (0)
Results o f a P rospective T rial o f M antle I rradiation A lone for S elected P atients W ith E arly-Stage H odgkin's D isease (2001) (0)
Peri-transplant Radiation Therapy for Non-Hodgkin Lymphoma (2010) (0)
Prognostic factors for patients with hodgkin disease in first relapse (0)
A Prospective Study on Pulmonary Function in Patients Receiving Hodgkin’s Disease Therapy. (2004) (0)
Second malignancies after pediatric Hodgkin lymphoma: Associations with radiation dose and volume (2004) (0)
Should lymphocyte predominance Hodgkin’s disease be treated like classical Hodgkin’s disease? (1999) (0)
with or without chemotherapy: long-term risks and risk factors Second malignancy after Hodgkin disease treated with radiation therapy (2013) (0)
303C Hodgkin's disease part 1: Pathology, staging, and management of early stage disease (1995) (0)
Treatment of early stage diffuse large B cell lymphoma, including mediastinal large cell lymphoma (1999) (0)
The role of combined modality therapy in symptomatic Hodgkin's disease, stage IB–IIIB (1980) (0)
Concurrent management of low-risk prostate cancer and localized small lymphocytic lymphoma in a man without competing risks despite advanced age (2014) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Peter M. Mauch?

Peter M. Mauch is affiliated with the following schools: